| HLA-B* 5701 screening for hypersensitivity to abacavir S Mallal, E Phillips, G Carosi, JM Molina, C Workman, J Tomažič, ... New England Journal of Medicine 358 (6), 568-579, 2008 | 2181 | 2008 |
| Combination antiretroviral therapy and the risk of myocardial infarction Data Collection on Adverse Events of Anti-HIV Drugs (DAD) Study Group New England Journal of Medicine 349 (21), 1993-2003, 2003 | 2127 | 2003 |
| Association between presence of HLA-B* 5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir S Mallal, D Nolan, C Witt, G Masel, AM Martin, C Moore, D Sayer, ... The Lancet 359 (9308), 727-732, 2002 | 1756 | 2002 |
| A whole-genome association study of major determinants for host control of HIV-1 J Fellay, KV Shianna, D Ge, S Colombo, B Ledergerber, M Weale, ... science 317 (5840), 944-947, 2007 | 1524 | 2007 |
| Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans J Mateus, A Grifoni, A Tarke, J Sidney, SI Ramirez, JM Dan, ZC Burger, ... Science 370 (6512), 89-94, 2020 | 1203 | 2020 |
| Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D: A: D study: a multi-cohort collaboration D: A: D Study Group The Lancet 371 (9622), 1417-1426, 2008 | 1183 | 2008 |
| Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA P Kiepiela, AJ Leslie, I Honeyborne, D Ramduth, C Thobakgale, S Chetty, ... Nature 432 (7018), 769-775, 2004 | 1012 | 2004 |
| Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level CB Moore, M John, IR James, FT Christiansen, CS Witt, SA Mallal Science 296 (5572), 1439-1443, 2002 | 931 | 2002 |
| T cells from patients with Parkinson’s disease recognize α-synuclein peptides D Sulzer, RN Alcalay, F Garretti, L Cote, E Kanter, J Agin-Liebes, C Liong, ... Nature 546 (7660), 656-661, 2017 | 786 | 2017 |
| Single-cell RNA sequencing reveals profibrotic roles of distinct epithelial and mesenchymal lineages in pulmonary fibrosis AC Habermann, AJ Gutierrez, LT Bui, SL Yahn, NI Winters, CL Calvi, ... Science advances 6 (28), eaba1972, 2020 | 775 | 2020 |
| SARS-CoV-2 vaccination induces immunological T cell memory able to cross-recognize variants from Alpha to Omicron A Tarke, CH Coelho, Z Zhang, JM Dan, ED Yu, N Methot, NI Bloom, ... Cell 185 (5), 847-859. e11, 2022 | 744 | 2022 |
| The genetic basis for the association of the 8.1 ancestral haplotype (A1, B8, DR3) with multiple immunopathological diseases P Price, C Witt, R Allock, D Sayer, M Garlepp, CC Kok, M French, S Mallal, ... Immunological reviews 167 (1), 257-274, 1999 | 638 | 1999 |
| Contribution of nucleoside analogue reverse transcriptase inhibitors to subcutaneous fat wasting in patients with HIV infection SA Mallal, M John, CB Moore, IR James, EJ McKinnon Aids 14 (10), 1309-1316, 2000 | 630 | 2000 |
| Immune restoration disease after the treatment of immunodeficient HIV‐infected patients with highly active antiretroviral therapy MA French, N Lenzo, M John, SA Mallal, EJ McKinnon, IR James, P Price, ... HIV medicine 1 (2), 107-115, 2000 | 570 | 2000 |
| Predisposition to abacavir hypersensitivity conferred by HLA-B* 5701 and a haplotypic Hsp70-Hom variant AM Martin, D Nolan, S Gaudieri, CA Almeida, R Nolan, I James, ... Proceedings of the National Academy of Sciences 101 (12), 4180-4185, 2004 | 568 | 2004 |
| Adaptation of HIV-1 to human leukocyte antigen class I Y Kawashima, K Pfafferott, J Frater, P Matthews, R Payne, M Addo, ... Nature 458 (7238), 641-645, 2009 | 561 | 2009 |
| RAS/MAPK activation is associated with reduced tumor-infiltrating lymphocytes in triple-negative breast cancer: therapeutic cooperation between MEK and PD-1/PD-L1 immune … S Loi, S Dushyanthen, PA Beavis, R Salgado, C Denkert, P Savas, ... Clinical Cancer Research 22 (6), 1499-1509, 2016 | 547 | 2016 |
| Comprehensive analysis of T cell immunodominance and immunoprevalence of SARS-CoV-2 epitopes in COVID-19 cases A Tarke, J Sidney, CK Kidd, JM Dan, SI Ramirez, ED Yu, J Mateus, ... Cell Reports Medicine 2 (2), 2021 | 523 | 2021 |
| Common genetic variation and the control of HIV-1 in humans J Fellay, D Ge, KV Shianna, S Colombo, B Ledergerber, ET Cirulli, ... PLoS genetics 5 (12), e1000791, 2009 | 480 | 2009 |
| Drug hypersensitivity caused by alteration of the MHC-presented self-peptide repertoire DA Ostrov, BJ Grant, YA Pompeu, J Sidney, M Harndahl, S Southwood, ... Proceedings of the National Academy of Sciences 109 (25), 9959-9964, 2012 | 479 | 2012 |
